C. Aguilar and L. Rodríguez-Delfín, “Effects of spironolactone administration on the podocytes loss and progression of experimental diabetic nephropathy”, Rev Peru Med Exp Salud Publica, vol. 29, no. 4, Feb. 2014, doi: 10.17843/rpmesp.2012.294.393.